Market Cap

Novartis Market Capitalization:

Novartis AG

CHF185.40 Billion

CHF as of Jan. 1, 2024

US$220.27 Billion

business Novartis Company Profile

Novartis Main Stock Listing

SIX: NOVN

Market capitalization history of Novartis

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Novartis market cap

Date Market Cap YoY Change
Jan. 1, 2024 CHF185.40 B 3.11%
Jan. 1, 2023 CHF179.80 B 7.59%
Jan. 1, 2022 CHF167.12 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Company Description

Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products. It operates through two segments: Innovative Medicines, offering prescription drugs across various therapeutic areas, and Sandoz, which develops, manufactures, and markets finished dosage form medicines, and provides active pharmaceutical ingredients, biosimilars, and biotechnology manufacturing services. Novartis collaborates with various entities to enhance its product offerings.

business Novartis Company Profile

Stocks & Indices

Novartis AG has the following listings and related stock indices.


Stock: SIX: NOVN

Stock: BCBA: NVS

Stock: Bovespa: N1VS34

Stock: NYSE: NVS

Stock: OTC: NVSEF

Stock: SIX: NOVNEE

Stock: FSX: NOTA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.